CARDIOVASCULAR HEALTH LIVING A HEART HEALTHY LIFE. Matt Handley MD Group Health Physicians

Similar documents
Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

No relevant financial relationships

No relevant financial relationships

Placebo-Controlled Statin Trials

Controversies in Preventative Cardiology

Prevention Strategies: Wisdom and Folly

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

NUTRITION IN THE AGE OF EVIDENCE D A N A H. M A N N I N G P H A R M. D., R. D., L D N

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Conflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Misperceptions still exist that cardiovascular disease is not a real problem for women.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Managing Cholesterol

Session 21: Heart Health

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

Disclosures No relationships (not even to an employer) No off-label uses. Cholesterol Lowering Guidelines: What now?

Hyperlipidemia. Intern Immersion Block 2015

Providing High Value Cost-Conscious Care:

Prevention of MACROvascular Complications of Diabetes

Hypertension Management Controversies in the Elderly Patient

Health Screens You Need and When You Need Them

INFLAMATION AND CANCER

NEW GUIDELINES FOR CHOLESTEROL

Optimizing Health While Aging with HIV

Creating Healthier Lives. Cholesterol Reduction Complex Lower Your Cholesterol Naturally

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

Primary Prevention of Cardiovascular Disease (CVD) Events with Statins. 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins

Magic Potions: Evidence-Based Diet Solutions for Diabetes and Weight Management Monica A. Dixon, Ph.D., R.D.

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Dyslipidemia: Lots of Good Evidence, Less Good Interpretation.

Coronary Artery Disease Clinical Practice Guidelines

Myth Busters. Dr Michael Mosley. Science Presenter #HCA2015

Treating Lipids for Prevention of CAD in Women: Matching Therapy to Risk

The Heart of a Woman:

The WorkCare Group, Inc. Content used with permission. StayWell is a registered trademark of The StayWell Company. All rights reserved.

Cardiovascular Disease

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

The Gender Divide Women, Men and Heart Disease February 2017

Weight Loss NOTES. [Diploma in Weight Loss]

The Cost of Poor Nutrition. Achieving Wellness. Did You Know? 5/29/2014. Reduced. Significant. Chronic. Financial Risk. Quality of. Life.

SESSION 3 11 AM 12:30 PM

High Blood Cholesterol What you need to know

Prevention of Heart Disease. Giridhar Vedala, MD Cardiovascular Medicine

Your Name & Phone Number Here! Longevity Index

Women and Heart Disease

HEART HEALTH. Anjanette Fraser. The Natural Alternative Health & Wellbeing Ltd

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Lipids What s new? Meera Jain, MD Providence Portland Medical Center

FACTSHEET CHOLESTEROL. What is cholesterol? Why is too much cholesterol harmful?

Heart Disease Genesis

Imaging-Guided Statin Allocation: Seeing Is Believing

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice

Aspirin as a Tool to Improve Heart Health Now! 1 Aspirin as a Tool to Improve Heart Health Now!

Do You Know Your Cholesterol Levels? Healthy Hearts, Healthy Homes

Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College

Clinical Recommendations: Patients with Periodontitis

Diabetes and Heart Disease

Heart Disease in Women. Charlotte A. Lee, M.D., DBIM, FLMI

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Women and Vascular Disease

overweight you are part of it!... Healthier, fitter, safer... Seafarers Health Information Programme ICSW S.H.I.P.

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Subject Expert. Michelle Whaley MSN, CNS, CCNS, ANVP-BC Swedish Medical Center Englewood, CO

Disclosures. Objectives. Cardiovascular Risk. Patient Case. JUPITER: The final frontier in statin utilization or an idea from outer space?

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010

Statins and Cholesterol. Noreen Devanney Primary Care Pharmacist Surrey Heath CCG

HEART HEALTH AND HEALTHY EATING HABITS

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!!

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Blood Pressure LIMBO How Low To Go?

Normal cholesterol level for men over 50

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Overweight. You are part of it! Healthier, fitter, safer.

Are you eating a balanced diet?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Outline. What is Evidence-Based Practice? EVIDENCE-BASED PRACTICE. What EBP is Not:

The Skinny on Visceral Fat

Cardiovascular Disease in Women -Vive La Difference? Dr Homeyra Douglas Consultant Cardiologist Aintree University Hospital

Women and Coronary Artery Disease. Aren t Women Just Like Men?

Nutrition and Cancer. Prof. Suhad Bahijri

Coach on Call. Thank you for your interest in Lifestyle Changes as a Treatment Option. I hope you find this tip sheet helpful.

Where are we heading?

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

Prevention of Heart Disease. Melissa Kemp, DHSc, MPAS, PA-C Clinical Manager, Physician Assistant Concentra Urgent Care

Transcription:

CARDIOVASCULAR HEALTH LIVING A HEART HEALTHY LIFE Matt Handley MD Group Health Physicians

WILLIE SUTTON Add together your risk of dying from breast cancer and colon cancer (women), or prostate cancer and colon cancer (men) Multiply by 10 That s your risk of heart disease

MAKING SENSE OF SCIENCE Every week there is conflicting advice in the lay press about risks and benefits of different health issues So how do we manage this information to lead healthy lives? First - understand the basics about medical studies

Understanding Medical News What Different Studies are Good For Observational trials Look at what happens to people without influencing what care they get Good for identifying prognosis/risk, bad for understanding the effectiveness of treatments

Understanding Medical News What Different Studies are Good For Randomized trials - true experiments Take one population of patients and use random selection to determine what treatment they get (active or placebo) Known and unknown risks are equally distributed between the groups, so that the observed difference is from the treatments, not differences in other characteristics between the two groups Bad for understanding risk (very selected populations), good for understanding the effectiveness of treatment Challenges Expensive, often have non-generalizable populations or interventions

STUDY OUTCOMES POEMs Patient Oriented Evidence that Matters Mortality, heart attack, functional capacity, quality of life DOE Disease Oriented Evidence BP, cholesterol, tumor size

Lies, Damned Lies, and Statistics Benjamin Disraeli Look for the Absolute difference in outcomes, Example not the Relative difference 100 patients at risk take drug A - 2% have heart attack 100 patients at risk take Placebo - 3% have heart attack Relative risk reduction (the newspaper statistic) is (3%-2%) 3% Absolute risk reduction (what you need to know) is 3% - 2% = 1% = 33%

THE NUMBER NEEDED TO TREAT How many patients would need to be treated for a period of time for one patient to avoid a specific outcome? Relative Risk Reduction 33% Absolute risk reduction 1% NNT = 100

UNDERSTANDING RISK The likelihood of any treatment helping you is determined mostly by your baseline risk of the heart disease Example: two people, same treatment, different benefits 60 yo man, smokes, high BP, diabetes cholesterol 220, HDL 50-5 year risk is about 30%. Treatment that lowers risk by 30% NNT = 10 40 yo woman, nonsmoker, normal BP, same cholesterol, 5 year risk is about 1% Treatment that lowers risk by 30% NNT = 300

ESTIMATING RISK Cholesterol is not a measure of risk (or health) - it is one risk factor Risk factor counting systems do not work well Framingham equation is the best way to estimate risk Includes: age, gender, BP, chol/hdl, diabetes, smoking Does not include: family history of early CAD, diet, exercise, treatment

CONTROVERSIES IN ESTIMATING CVD RISK C reactive Protein Sub-fractions of cholesterol Heart Scam - calcium scoring The Metabolic Syndrome Tests are only useful if they provide information that would change a recommendation for care

CHOLESTEROL MEASUREMENT What cholesterol lab tests make sense? Total cholesterol and HDL are undeniably the best Do you need to know Triglycerides or LDL?

DIET AND HEALTH The micronutrient theory of diet Looking at components of food, rather than food itself (% calories from x and y) What does it build back into? Has yet to yield effective interventions

DIET STUDIES Observational studies Vegetables are good Lots of saturated fats are bad Mediterranean Diet is good and a miss... Vitamins are good for you Experimental studies - looking for POEMs Low fat diets - no benefits, and little adherence Mediterranean diet - 1/3 reduction in heart attacks and strokes, cancer and mortality and good adherence

EXERCISE Fitness Matters Weight, vascular disease, probably cancer, and most every aspect of QOL Exercise/Physical activity is a reasonable marker for fitness Dose response - diminishing returns after moderate fitness - more is better, but not much better The gym is not the answer - it is a bonus rather than the solution Successful improvements in physical activity usually include walking and social connection

TOBACCO The most important modifiable risk factor. Period

ASPIRIN There are risks and benefits For unknown reasons, aspirin prevents heart attacks in men and strokes in women 15% RRR, NNH is about 300 (GI bleeding) If your baseline risk is over 5%, there is a net benefit

BLOOD PRESSURE BP increases with age - most people develop HTN Lower is better if you aren t on treatment Only about 40% of people diagnosed are in good control, because: We overestimate impact of diet and exercise on BP We do not adjusts medications in the ways that have been shown to work best

STATINS While people focus on cholesterol, statins treat CVD risk Patients at equal CVD risk with high and low cholesterol have the same benefit Patients with large and small reductions in cholesterol on statins have the same benefit Statins are twice as effective as aspirin, and safer

CHOLESTEROL LOWERING DRUGS Five medications that have been shown to improve cholesterol effectively, but increase risk of CVD and death Combination therapy in the quest to treat the number has not been shown to be helpful in decreasing CVD

ALCOHOL & CHOCOLATE People who drink alcohol in moderation have less heart disease and live longer Most if not all of the effect is from alcohol (vs red wine) Alcohol causes enormous damage to health Chocolate may be beneficial - and tastes great